BioMarin Pharmaceutical
BMRN
$92.06
Share price
2.87%
Change (1 day)
-4.26%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Net assets
Net assets on the balance sheet as of December 2023 : $4.95 B
According to BioMarin Pharmaceutical's latest financial reports the company has $4.95 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
BioMarin Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $4.95 B | 7.57% |
| 2022-12-31 | $4.60 B | 7.91% |
| 2021-12-31 | $4.26 B | 3.89% |
| 2020-12-31 | $4.10 B | 31.5% |
| 2019-12-31 | $3.12 B | 5.2% |
| 2018-12-31 | $2.96 B | 5.67% |
| 2017-12-31 | $2.80 B | 1.53% |
| 2016-12-31 | $2.76 B | 15.22% |
| 2015-12-31 | $2.40 B | 57.13% |
| 2014-12-31 | $1.52 B | 13.93% |
| 2013-12-31 | $1.34 B | 32.02% |
| 2012-12-31 | $1.01 B | 31.4% |
| 2011-12-31 | $0.77 B | 7.78% |
| 2010-12-31 | $0.71 B | 122.62% |
| 2009-12-31 | $0.32 B | 16.45% |
| 2008-12-31 | $0.27 B | 47.38% |
| 2007-12-31 | $0.18 B | 59.36% |
| 2006-12-31 | $0.11 B | -252.08% |
| 2005-12-31 | $-77.47 M | 13.95% |
| 2004-12-31 | $-67.98 M | -157.68% |
| 2003-12-31 | $0.11 B | 19.6% |
| 2002-12-31 | $98.54 M | -38.24% |
| 2001-12-31 | $0.15 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $82.20 B | 1,560.15% | 🇫🇷 France |
 Ultragenyx RARE | $0.27 B | -94.44% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $82.88 M | -98.33% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.46 B | -109.19% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.16 B | -96.77% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.38 B | -92.17% | 🇺🇸 USA |